Shareholders' Equity (Details) - USD ($)	1 Months Ended			12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Stock Repurchase Program [Abstract]
Stock repurchase program, additional amount authorized			$ 2,000,000
Stock repurchase program authorized amount	$ 22,000,000			$ 22,000,000
Stock repurchased during period (in shares)				30,646
Amount paid to repurchase shares during the year				$ 881,966	$ 685,808
Amount of common stock repurchased	$ 20,191,403			$ 20,191,403
Number of common stock acquired (in shares)	1,356,859			1,356,859
Earnings Per Share [Abstract]
Basic weighted average shares outstanding (in shares)				3,176,757	3,167,719
Weighted average dilutive options outstanding (in shares)				0	0
Diluted weighted average shares outstanding (in shares)				3,176,757	3,167,719
Statutory Restrictions [Abstract]
Minimum statutory surplus required to maintain	$ 2,500,000			$ 2,500,000
Period from declaration of ordinary dividend requires notification to insurance commissioner				5 days
Minimum period prior to payment of dividend requires notification to insurance commissioner				10 days
Percentage of statutory capital and surplus	10.00%			10.00%
Ordinary dividends paid				$ 2,000,000	$ 3,000,000
Period for which no extraordinary dividends paid				2 years
Outside Directors [Member]
Share-based Compensation [Abstract]
Annual retainer fee paid to director				$ 5,000
Per meeting fee paid to director				$ 2,500
Number of shares issued (in shares)	4,246	4,485
Stock issued during period (in dollars per share)	$ 30.01	$ 25.06		$ 30.01	$ 25.06
Cost of shares issued				$ 127,422	$ 112,394
Management and Employees [Member]
Share-based Compensation [Abstract]
Number of shares issued (in shares)				26,911	17,963
Cost of shares issued				$ 674,390	$ 486,798